Fundamental dimension Equity attribute | ASPAPeer $27.05▲+116.40% Cap $65.20MP/E -82.0x QuantScore38/100 | AGBAPeer $1.40▲+14.75% Cap $66.24MP/E -0.7x QuantScore36/100 | ANNALeader $2.51▲+5.91% Cap $102.8MP/E 12.8x QuantScore69/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
75/100 |
73/100 |
26/100 |
Valuation Multiples, PEG & DCF upside | 47/100 | 50/100 | 100/100 |
Health Piotroski, Altman Z, leverage & liquidity | 30/100 | 23/100 | 54/100 |
Growth Revenue / earnings growth & margins | 0/100 | 0/100 | 98/100 |
Sentiment Analyst ratings, targets & revisions | — | — | — |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -82.0x | -0.7x | 12.8x |
Forward P/E (next FY) | — | — | — |
EV / EBITDA (TTM) | -0.0x | -0.9x | 4.0x |
Price / Sales | 0.0x | -0.0x | 2.6x |
Price / Free Cash Flow | -90.9x | -2.9x | 10.4x |
PEG ratio | 0.92 | 0.00 | 0.01 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 4 / 9 | 1 / 9 | 5 / 9 |
Altman Z-Score | -11.25 (Distress) | -254.19 (Distress) | 0.09 (Distress) |
Total debt / equity | 0.34 | -0.27 | 0.00 |
Quick ratio | 0.2x | 0.0x | 1.9x |
Interest coverage | — | 4.7x | — |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | — | -100.0% | +1663.0% |
Net income growth YoY | -182912.6% | -254.7% | +114.6% |
Gross margin (TTM) | 8.3% | -0.0% | 67.1% |
Operating margin (FY) | -54.8% | — | 11.6% |
FCF margin (FY) | -0.0% | — | 12.6% |
5. Trailing price performancePrice change over period |
1M return | +114.7% | -71.3% | -9.1% |
3M return | +147.5% | -68.3% | -24.6% |
6M return | +153.0% | -79.9% | -36.5% |
Year to date | +164.7% | +47.3% | -12.8% |
1Y return | +166.5% | +20.7% | -29.3% |
3Y return | +178.6% | -93.8% | -76.2% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | — — | — — | $37.25 +1384.1% upside |
Wall Street consensus target | — — | — — | — — |
Consensus stance | — | — | — |